Clinical Trial Update: Safety And Efficacy Of Maraviroc In Patients For HIV Patients (Regulatory Post Marketing Commitment Plan)

View source ↗

Summary

A completed regulatory post-marketing commitment study evaluating safety and efficacy of maraviroc in CCR5-tropic HIV-1 infection with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Maraviroc (maraviroc)

Snippet

Sponsor: ViiV Healthcare | Conditions: CCR5-tropic HIV-1 Infection | Status: COMPLETED | Results posted: 2020-01-02